Search results for "Percutaneous Mitral Valve Repair"

showing 4 items of 4 documents

Preoperative evaluation before MitraClip®: present and future perspective.

2014

ABSTRACT  Mitral regurgitation (MR) is the second most common heart valve disease worldwide. Currently, the management of MR is based on medical therapy (including biventricular pacing), surgery (mitral valve replacement or repair) and percutaneous therapy. However, in spite of guideline recommendations, 50% of individuals assessed in the Euro Heart Survey were not referred to surgical intervention due to comorbidities or real or perceived high risks for cardiac surgery; thus, in recent years, the focus of research has shifted to the development of percutaneous approaches to treat severe MR in order to restore valve function in a minimally invasive fashion. Among these techniques, the perc…

Heart Valve Prosthesis ImplantationMitral regurgitationmedicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentMitraClipPatient SelectionMitral valve replacementMitral Valve InsufficiencyGuidelineSurgeryCardiac surgerymedicine.anatomical_structureHeart Valve ProsthesisPreoperative CaremedicineMolecular MedicineHumansMitral ValveHeart valveCardiology and Cardiovascular MedicinebusinessPercutaneous Mitral Valve Repair
researchProduct

P2575Comparison of deep sedation with general anesthesia in patients undergoing percutaneous mitral valve repair (PMVR)

2018

business.industryAnesthesiaSedationMedicineIn patientmedicine.symptomCardiology and Cardiovascular MedicinebusinessPercutaneous Mitral Valve RepairEuropean Heart Journal
researchProduct

Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcathete…

2017

Aims The aim of the present study was to assess the safety and efficacy of percutaneous mitral valve repair using the MitraClip™ device in patients with severely reduced systolic left ventricular (LV) function. Methods and results Among 777 MitraClip™ implantations included in the German mitral valve registry, we identified 256 patients suffering from severely reduced LV function [ejection fraction (EF) 50%) and 280 patients presenting with an EF 30–50% prior to MitraClip™ therapy. High procedural success rates, low periprocedural complication rates, and low residual mitral regurgitation grades at discharge were achieved throughout all groups. In-hospital mortality was low and comparable in…

medicine.medical_specialtyMitral regurgitationEjection fractionbusiness.industryMortality rateMitraClip030204 cardiovascular system & hematologymedicine.disease3. Good healthSurgery03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureInternal medicineMitral valveHeart failuremedicineCardiology030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessComplicationPercutaneous Mitral Valve RepairEuropean Journal of Heart Failure
researchProduct

2017

Background Percutaneous edge‐to‐edge mitral valve repair ( PMVR ) has become an established treatment option for mitral regurgitation in patients not eligible for surgical repair. Currently, most procedures are performed under general anesthesia ( GA ). An increasing number of centers, however, are performing the procedure under deep sedation ( DS ). Here, we compared patients undergoing PMVR with GA or DS . Methods and Results A total of 271 consecutive patients underwent PMVR at our institution between May 2014 and December 2016. Seventy‐two procedures were performed under GA and 199 procedures under DS . We observed that in the DS group, doses of propofol (743±228 mg for GA versus 369±2…

Surgical repairMitral regurgitationMitral valve repairbusiness.industrySedationmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureMitral valveAnesthesiamedicine030212 general & internal medicinemedicine.symptomCardiology and Cardiovascular MedicinePropofolbusinessPercutaneous Mitral Valve RepairCardiac catheterizationmedicine.drugJournal of the American Heart Association
researchProduct